Look for Drugs and Conditions



It is a novel MT1 and MT2 melatonin receptor selective agonist used for the treatment of insomnia characterized by difficulty in sleep onset.


insomnia associated with difficulty in onset of sleep


Oral; 8mg half hour before going to bed

Special Precautions

Sleep disturbance may occur Paediatric: Data not sufficient Pregnancy: category C. Lactation: Data not sufficient. Elderly: No differences were observed in safety or efficacy between elderly and younger adult subjects.

Side Effects

Somnolence, fatigue, dizziness, nausea

Drug Interactions

Fluvoxamine,Rifampin, Ketoconazole, Fluconazole, Donepezil, Doxepin.

Ad 5